Syed Ahsan Ali Shah, et al. “BISPECIFIC ANTIBODIES IN RELAPSED REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC REVIEW OF EFFICACY AND SAFETY IN PHASE I II III CLINICAL TRIAL”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 31, no. 3, Mar. 2024, pp. 622-9, https://doi.org/10.53555/jptcp.v31i3.4993.